Nerio Therapeutics
Novel oncology therapeutics targeting cancer cell biology
- Sector
- Biotech
- Headquarters
- LA JOLLA, CA
- Founded
- 2019
- Latest Form D
- $3.5M, Oct 2021
- Total capital
- $6.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $6.5M
- 2 Form D · last Oct 2021
- 61 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 20 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$3.5M
- Private capital raisedForm D · SEC · 1st filing$3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Jay J. Lichter, Ph.D.DirectorNamed in SEC Form D filings
- Sanford J. Madigan, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
- Stefan J. HellerDirectorNamed in SEC Form D filings
- Tighe J. ReardonExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 20- PendingProtein Tyrosine Phosphatase Inhibitors And Uses ThereofUSPTOApplication 18855786
- PendingProtein Tyrosine Phosphatase Inhibitors And Uses ThereofUSPTOApplication 18834755
- PendingProtein Tyrosine Phosphatase Inhibitors And Uses ThereofUSPTOApplication 18834761
Show all 20 patent records
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofAug 14, 2025 · Application 18855786Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofMay 1, 2025 · Application 18834755Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofMay 1, 2025 · Application 18834761Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApr 24, 2025 · Application 18834765Pending
- Protein Tyrosine Phosphatase Inhibitor CombinationsApplication 63517196Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication PCTUS2023018508Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63486559Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication PCTUS2023012092Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication PCTUS2023061727Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication PCTUS2023061714Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63331073Pending
- Tricyclic Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63305783Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63305786Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63305788Pending
- Protein Tyrosine Phosphatase Inhibitors And Uses ThereofApplication 63305789Pending
- Protein Tyrosine Phosphatase Degraders And Uses ThereofApplication 19507868Pending
- Protein Tyrosine Phosphatase Inhibitor CombinationsApplication 19507872Pending
- Protein Tyrosine Phosphatase Degraders And Uses ThereofApplication PCTUS2024040522Pending
- Protein Tyrosine Phosphatase Inhibitor CombinationsApplication PCTUS2024040524Pending
- Protein Tyrosine Phosphatase Degraders And Uses ThereofApplication 63517192Pending
Related companies, and why
- RHEUMAGEN, INC.Similar federal contract value in Biotech · null in contracts
- BioLineRx Ltd.Similar federal contract value in Biotech · null in contracts
- NANOPHARMACEUTICALS, LLCSimilar federal contract value in Biotech · null in contracts
- Zafrens Inc.Similar federal contract value in Biotech · null in contracts
- Invenra Inc.Similar federal contract value in Biotech · null in contracts
- LEUKOGENE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .